Amorosa Valerianna, Synnestvedt Marie, Gross Robert, Friedman Harvey, MacGregor Rob Roy, Gudonis Debie, Frank Ian, Tebas Pablo
Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA 19104-6073, USA.
J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):557-61.
Obesity and HIV infection are ongoing epidemics in the United States. Obesity predisposes to diabetes and cardiovascular disease, which are complications also associated with HIV and/or its treatment.
To determine the prevalence and risk factors for overweight and obesity in HIV-infected individuals.
Retrospective cross-sectional study in which 1689 patients enrolled in the University of Pennsylvania Center for AIDS Research Adult/Adolescent Database at 1 university hospital clinic, 2 affiliated practices, and 1 Veterans Administration clinic in Philadelphia had demographic, social, and medical data collected prospectively since 1999.
Body mass index (BMI) data were available for 1669 HIV-infected subjects: 78% were men, and 60% were African American. The median CD4 count was 381 cells/microL, 47% of subjects had a viral load <400 copies/mL, and 9% of subjects were treatment naive.
The prevalence and risk factors for overweight (BMI: 25-29.9 kg/m) and obesity (BMI>or=30 kg/m) in HIV-infected subjects.
Obesity and overweight were more prevalent than wasting (14%, 31%, and 9%, respectively; P<0.0005), but they were not more common than in the general population. Although women and men were equally overweight (30% vs. 31%), women were more obese than men (28% vs. 11%; P<0.001). Among women, African American race (odds ratio [OR]=1.8, 95% confidence interval [CI]: 1.1-2.9) and a CD4 count>or=200 cells/microL (OR=2.8, 95% CI: 1.6-4.9) were associated with overweight and obesity. Among men, only a CD4 count>or=200 cells/microL (OR=1.6, 95% CI: 1.04-2.4) was associated with increased BMI. In men and women, smoking was associated with decreased obesity and overweight (OR=0.59, 95% CI: 0.47-0.74 and OR=0.65, 95% CI: 0.43-0.98, respectively). Age, income, employment, education, past or current intravenous drugs, being on HIV treatment, and viral load were not associated with obesity in the multivariate model. There was a positive correlation between BMI and total cholesterol, triglycerides, and glucose.
Obesity is more common than wasting in this therapeutic era. Women, particularly those of African American race, are at high risk. Obesity might add to metabolic abnormalities associated with HIV or its treatment and contribute to morbidity, as patients with HIV live longer.
肥胖和艾滋病毒感染在美国仍是不断蔓延的流行病。肥胖易引发糖尿病和心血管疾病,而这些并发症也与艾滋病毒和/或其治疗相关。
确定艾滋病毒感染者中超重和肥胖的患病率及危险因素。
回顾性横断面研究,自1999年起前瞻性收集了费城1所大学医院诊所、2个附属医疗机构及1个退伍军人管理局诊所参与宾夕法尼亚大学艾滋病研究中心成人/青少年数据库的1689例患者的人口统计学、社会和医学数据。
1669例艾滋病毒感染者有体重指数(BMI)数据:78%为男性,60%为非裔美国人。CD4细胞计数中位数为381个/微升,47%的受试者病毒载量<400拷贝/毫升,9%的受试者未接受过治疗。
艾滋病毒感染者中超重(BMI:25 - 29.9千克/平方米)和肥胖(BMI≥30千克/平方米)的患病率及危险因素。
肥胖和超重比消瘦更常见(分别为14%、31%和9%;P<0.0005),但并不比普通人群更普遍。虽然女性和男性超重比例相当(30%对31%),但女性肥胖比例高于男性(28%对11%;P<0.001)。在女性中,非裔美国人种(比值比[OR]=1.8,95%置信区间[CI]:1.1 - 2.9)和CD4细胞计数≥200个/微升(OR=2.8,95%CI:1.6 - 4.9)与超重和肥胖相关。在男性中,只有CD4细胞计数≥200个/微升(OR=1.6,95%CI:1.04 - 2.4)与BMI升高相关。在男性和女性中,吸烟与肥胖和超重减少相关(分别为OR=0.59,95%CI:0.47 - 0.74和OR=0.65,95%CI:0.43 - 0.98)。在多变量模型中,年龄、收入、就业、教育、既往或当前静脉吸毒、接受艾滋病毒治疗及病毒载量与肥胖无关。BMI与总胆固醇、甘油三酯和血糖呈正相关。
在这个治疗时代,肥胖比消瘦更常见。女性,尤其是非裔美国女性,风险较高。随着艾滋病毒感染者寿命延长,肥胖可能会增加与艾滋病毒或其治疗相关的代谢异常,并导致发病。